Clemens Mellink

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

Dimitri Breems, Wim L.J. van Putten, Georgine E. de Greef et al. · Journal of Clinical Oncology · 2008 · 577 citations · Full text

Life Sciences, Hematology, Oncology +17

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Arnon P. Kater, Jenny Wu, Thomas J. Kipps et al. · Journal of Clinical Oncology · 2020 · 220 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

John F. Seymour, Thomas J. Kipps, Barbara Eichhorst et al. · Blood · 2022 · 151 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1

Onno Leeksma, Tanja A.E. van Achterberg, Yoshikazu Tsumura et al. · European Journal of Biochemistry · 2002 · 100 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship

Taco W. Kuijpers, Mariel Alders, Anton T. J. Tool et al. · Blood · 2005 · 95 citations · Full text

Life Sciences, Genetics, Hematology +16